2017
DOI: 10.1007/s00417-017-3839-y
|View full text |Cite
|
Sign up to set email alerts
|

OCT-based deep learning algorithm for the evaluation of treatment indication with anti-vascular endothelial growth factor medications

Abstract: Deep artificial neural networks show impressive performance on classification of retinal OCT scans. After training on historical clinical data, machine learning methods can offer the clinician support in the decision-making process. Care should be taken not to mistake neural network output as treatment recommendation and to ensure a final thorough evaluation by the treating physician.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
39
0
4

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 95 publications
(46 citation statements)
references
References 13 publications
1
39
0
4
Order By: Relevance
“…To our knowledge, this is the first time that DL has been shown to accurately accomplish such a challenging task in the field of ophthalmic imaging (i.e., reproducing three-dimensional clinical measurements from two-dimensional clinical images). This finding, together with what has been shown in previous studies, [18][19][20][21][22][23][24][25][26][27][28] underlines the value of DL in enhancing ophthalmic disease surveillance through an automated approach. Our study showed that DL models can accurately identify which CFPs are associated with a clinically significant level of MT.…”
Section: Discussionsupporting
confidence: 82%
See 1 more Smart Citation
“…To our knowledge, this is the first time that DL has been shown to accurately accomplish such a challenging task in the field of ophthalmic imaging (i.e., reproducing three-dimensional clinical measurements from two-dimensional clinical images). This finding, together with what has been shown in previous studies, [18][19][20][21][22][23][24][25][26][27][28] underlines the value of DL in enhancing ophthalmic disease surveillance through an automated approach. Our study showed that DL models can accurately identify which CFPs are associated with a clinically significant level of MT.…”
Section: Discussionsupporting
confidence: 82%
“…17 In recent years, DL has gained an incredible momentum in the field of clinical ophthalmology and has opened up new possibilities for the automated detection of anomalies and grading of retinal diseases. [18][19][20][21][22][23][24][25][26][27][28] Compared to feature-based machine learning, DL has the advantage of offering an end-toend solution between raw images and a selected outcome variable. Consequently, DL does not require the specification of known clinical features to construct a detection model, as DL learns directly from raw images without being limited by a priori assumptions on the information contained by the images themselves.…”
mentioning
confidence: 99%
“…At present, multiple DLSs have been developed based on OCT in ophthalmology, such as referable retina diseases detection, 27,28 glaucoma quantification and classification, [29][30][31] and antivascular endothelial growth factor treatment. 32 These studies perfectly underscored the promise of DL to lower the cost of disease interpretation from OCT images. Hence, it would be necessary to filter out ungradable images beforehand for a better precision.…”
Section: Discussionmentioning
confidence: 77%
“…AI has been applied to various adult ophthalmic diseases, including diabetic retinopathy [1,[74][75][76][77], AMD [78][79][80][81][82][83], sight-threatening retinal disease [2,[84][85][86][87][88][89], glaucoma [90][91][92], intraocular lens calculation [93], and keratoconus [94]. It has also been used for robotassisted repair of epiretinal membranes [95], retinal vessel segmentation [96][97][98][99], and systemic disease prediction from fundus images [100].…”
Section: Non-pediatric Applicationsmentioning
confidence: 99%